Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Geographic atrophy secondary to age-related macular degeneration: Significance of lesion location and functional determinants to vision-related quality of life
Author Affiliations & Notes
  • Eliza Eliza Broadbent
    University of Utah Hospital, Salt Lake City, Utah, United States
  • Sandrine H. Künzel
    Rheinische Friedrich-Wilhelms-Universitat Bonn, Bonn, Nordrhein-Westfalen, Germany
  • Philipp Möller
    Rheinische Friedrich-Wilhelms-Universitat Bonn, Bonn, Nordrhein-Westfalen, Germany
  • Moritz Linder
    Philipps Universitat Marburg Institut fur Physiologie und Pathophysiologie, Marburg, Hessen, Germany
    University of Oxford Nuffield Laboratory of Ophthalmology, Oxford, Oxfordshire, United Kingdom
  • Lukas Goerdt
    Rheinische Friedrich-Wilhelms-Universitat Bonn, Bonn, Nordrhein-Westfalen, Germany
  • Joanna Czauderna
    Rheinische Friedrich-Wilhelms-Universitat Bonn, Bonn, Nordrhein-Westfalen, Germany
  • Steffen Schmitz-Valckenberg
    University of Utah Hospital, Salt Lake City, Utah, United States
  • Frank G Holz
    Rheinische Friedrich-Wilhelms-Universitat Bonn, Bonn, Nordrhein-Westfalen, Germany
  • Maximilian Pfau
    Institute of Molecular and Clinical Ophthalmology Basel, Basel, Basel-Stadt, Switzerland
  • Monika Fleckenstein
    University of Utah Hospital, Salt Lake City, Utah, United States
  • Footnotes
    Commercial Relationships   Eliza Broadbent None; Sandrine H. Künzel None; Philipp Möller None; Moritz Linder None; Lukas Goerdt None; Joanna Czauderna None; Steffen Schmitz-Valckenberg AlphaRET, Apellis, Bioeq, Galimedix, Katairo, Kubota Vision, Novartis, PerceiveBiotherapeutics, Pixium, Roche, SparingVision, Code C (Consultant/Contractor), Bayer, Carl Zeiss MediTec, Heidelberg Engineering, Novartis, Roche, Code F (Financial Support), Apellis, Heidelberg Engineering, Code R (Recipient); Frank Holz Acucela, Alexion, Alzheon, Apellis, Astellas, Bayer, Boehringer Ingelheim, Formycon, Roche/Genentech, Geuder, Grayburg, Gyroscope, HeidelbergEngineering, IvericBio, Janssen, Kanghong, LinBioscience, Novartis, Oxurion, Pixium, StealthBioTherapeutics, Zeiss, Code C (Consultant/Contractor), Acucela, Allergan, Apellis, Bayer, Formycon, CenterVue,Roche/Genentech, Geuder, Heidelberg Engineering, IvericBio, Kanghong, Novartis, Optos, Pixium Vision, Zeiss, Code F (Financial Support), GRADE Reading Center, Code O (Owner); Maximilian Pfau Apellis Pharmaceuticals, Janssen Pharmaceutica, Daiichi Sankyo, Code C (Consultant/Contractor), CenterVue , Code F (Financial Support); Monika Fleckenstein None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 5973. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Eliza Eliza Broadbent, Sandrine H. Künzel, Philipp Möller, Moritz Linder, Lukas Goerdt, Joanna Czauderna, Steffen Schmitz-Valckenberg, Frank G Holz, Maximilian Pfau, Monika Fleckenstein; Geographic atrophy secondary to age-related macular degeneration: Significance of lesion location and functional determinants to vision-related quality of life. Invest. Ophthalmol. Vis. Sci. 2024;65(7):5973.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The primary objective of our study was to quantify the impact of geographic atrophy (GA) secondary to age-related macular degeneration on vision-related quality of life (VRQoL). Recognizing the limitations of traditional biomarkers like lesion size and best-corrected visual acuity (BCVA), our research utilizes patient-reported outcomes to understand how GA characteristics affect daily living. We aim to determine which parameters of GA, including lesion location and visual function parameters, are most influential in shaping VRQoL.

Methods : This was a prospective, non-interventional, natural history study of 82 patients with bilateral GA. Lesion size and location was determined using the Early Treatment Diabetic Retinopathy (ETDRS) grid subfields aligned to the fundus autofluorescence image, BCVA, low-luminance visual acuity (LLVA), reading acuity, and reading speed. VRQoL was measured using the National Eye Institute Visual Function Questionnaire 25 (NEI VFQ-25), which includes subscales for near and distance activities. We applied linear mixed-effects models with the least absolute shrinkage and selection operator for variable selection. Correlations of the GA parameters with VRQoL scores were applied for both the entire group and the subset with foveal-sparing GA.

Results : Participants had an average total GA area of 2.9 ± 1.2 mm2 in the better eye (BE) and 3.1 ± 1.3 mm2 in the worse eye (WE). LLVA emerged as the most salient factor for the composite VRQoL score. The inner lower subfield of the BE had the strongest association with the distance activities subscale, while the inner left subfield of the BE was most highly associated with near activities (Figure 1). For participants with foveal-sparing GA, LLVA of the better eye was the most important variable across all VRQoL scales.

Conclusions : Our study found that the inner lower and inner left subfields of the BE are key for VRQoL. For foveal-sparing patients, LLVA emerged as an important factor. Recent approval of drugs to slow the progression of GA makes it increasingly critical to understand how GA characteristics influence VRQoL. Our findings highlight the value of targeted assessments of GA lesion location and visual function in optimizing treatment strategies.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

Figure 1. Univariate regression of functional determinants, structural determinants, and ETDRS subfields with VRQoL.

Figure 1. Univariate regression of functional determinants, structural determinants, and ETDRS subfields with VRQoL.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×